Moody Aldrich Partners LLC

Position in CRNX — Crinetics Pharmaceuticals, Inc.

CIK 936941 MARBLEHEAD, MA

Position in CRNX

as of Jun 30, 2026 · filed Jul 15, 2026 Compact

Position Value

$5,466,201

-$1,196,267 QoQ

Shares Held

146,077

-20.4% QoQ

Ownership

0.138%

of shares outstanding

% of Portfolio

0.98%

of 13F equity value

Holder Rank

#64

of 264 holders

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 47% Shared 37% None 17%

Healthcare · as of Jun 30, 2026

Moody Aldrich Partners LLC holds $91,411,685 across 28 Biotechnology names. CRNX ranks #6 (6.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ORKA	Oruka Therapeutics, Inc.	101,411	$9,651,284
2	LGND	Ligand Pharmaceuticals Inc	28,160	$8,901,094
3	PTGX	Protagonist Therapeutics, Inc	59,601	$7,305,890
4	DNTH	Dianthus Therapeutics, Inc. /DE/	74,552	$7,267,328
5	PRAX	Praxis Precision Medicines, Inc.	19,066	$6,383,106
6	CRNX	Crinetics Pharmaceuticals, Inc. This page	146,077	$5,466,201
7	NKTR	Nektar Therapeutics	64,135	$4,477,264
8	CAPR	Capricor Therapeutics, Inc.	177,754	$4,280,316

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,466,201	146,077	-20.4%	Shares	Sole	2026-07-15
2026-03-31	$6,662,468	183,438	+66.1%	Shares	Sole	2026-04-20
2025-12-31	$5,139,818	110,415	-4.4%	Shares	Sole	2026-01-30
2025-09-30	$4,812,365	115,543	-16.1%	Shares	Sole	2025-10-21
2025-06-30	$3,963,012	137,796	-1.5%	Shares	Sole	2025-08-04
2025-03-31	$4,692,413	139,905	-3.1%	Shares	Sole	2025-04-29
2024-12-31	$7,381,433	144,366	+3.8%	Shares	Sole	2025-01-23
2024-09-30	$7,109,543	139,130	-7.4%	Shares	Sole	2024-10-22
2024-06-30	$6,726,696	150,183	+166.3%	Shares	Sole	2024-07-24
2024-03-31	$2,640,177	56,402	-9.0%	Shares	Sole	2024-04-30
2023-09-30	$1,843,255	61,979	—	Shares	Sole	2023-11-08
No filing history on record for this holder in this stock.